If you’ve ever endured the ordeal of being a human pincushion during a routine blood draw, your salvation has finally arrived. Vitestro’s Aletta, a sophisticated autonomous phlebotomy robot, has just bagged FDA clearance after clinical trials demonstrated a 94.5% first-attempt success rate—even for those of us with notoriously ’tricky’ veins. By blending near-infrared and ultrasound imaging with sharp AI, this device is officially more reliable than many of its human counterparts, and a single supervisor can manage three of them simultaneously. It’s a brilliant bit of kit, though phlebotomists might be starting to feel a bit of a chill regarding their job security.
